Identification of conserved immunogenic peptides of SARS-CoV-2 nucleocapsid protein

References

• Adhikari, U. K., Tayebi, M., & Mizanur Rahman, M. (2018). Immunoinformatics approach for epitope-based peptide vaccine design and active site prediction against polyprotein of emerging oropouche virus. Journal of Immunology Research, 2018, 6718083–6718022. https://doi.org/10.1155/2018/6718083
   PubMed Web of Science ®Google Scholar
• Ayaz Anwar, M., & Choi, S. (2017). Structure-activity relationship in TLR4 mutations: Atomistic molecular dynamics simulations and residue interaction network analysis. OPEN. https://doi.org/10.1038/srep43807
   Google Scholar
• Bai, Z., Cao, Y., Liu, W., Li, J., Lundstrom, K., & Davidson, A. (2021). The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation. Viruses, 13(6), 1115. https://doi.org/10.3390/v13061115
   PubMed Web of Science ®Google Scholar
• Bui, H. H., Sidney, J., Dinh, K., Southwood, S., Newman, M. J., & Sette, A. (2006). Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics, 7(1), 153. https://doi.org/10.1186/1471-2105-7-153
   PubMed Web of Science ®Google Scholar
• Bui, H. H., Sidney, J., Li, W., Fusseder, N., & Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics, 8(1), 361. https://doi.org/10.1186/1471-2105-8-361
   PubMed Web of Science ®Google Scholar
• Chavda, V. P., Balar, P., Vaghela, D., Solanki, H. K., Vaishnav, A., Hala, V., & Vora, L. (2023). Omicron variant of SARS-CoV-2: An Indian perspective of vaccination and management. Vaccines, 11(1), 160. https://doi.org/10.3390/vaccines11010160
   Web of Science ®Google Scholar
• Crooke, S. N., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2020). Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Scientific Reports, 10(1), 14179. https://doi.org/10.1038/s41598-020-70864-8
   PubMed Web of Science ®Google Scholar
• Dimitrov, I., Bangov, I., Flower, D. R., & Doytchinova, I. (2014). AllerTOP v.2 – A server for in silico prediction of allergens. Journal of Molecular Modeling, 20(6), 1-6. https://doi.org/10.1007/s00894-014-2278-5
   PubMed Web of Science ®Google Scholar
• Do, M. D., Le, L. G. H., Nguyen, V. T., Dang, T. N., Nguyen, N. H., Vu, H. A., & Mai, T. P. (2020). High-resolution HLA typing of HLA-A, -B, -C, -DRB1, and -DQB1 in Kinh Vietnamese by using next-generation sequencing. Frontiers in Genetics, 11, 383. https://doi.org/10.3389/FGENE.2020.00383/BIBTEX
   PubMed Web of Science ®Google Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8(1), 1–7. https://doi.org/10.1186/1471-2105-8-4
   PubMedGoogle Scholar
• EMBL-EBI. (2022). IPD-IMGT/HLA database. https://www.ebi.ac.uk/ipd/imgt/hla/about/statistics/
   Google Scholar
• Feng, W., Xiang, Y., Wu, L., Chen, Z., Li, Q., Chen, J., Guo, Y., Xia, D., Chen, N., Zhang, L., Zhu, S., & Zhao, K. N. (2022). Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine. Journal of Clinical Laboratory Analysis, 36(6), e24479. https://doi.org/10.1002/jcla.24479
   PubMed Web of Science ®Google Scholar
• Fenoglio, D., Traverso, P., Parodi, A., Tomasello, L., Negrini, S., Kalli, F., Battaglia, F., Ferrera, F., Sciallero, S., Murdaca, G., Setti, M., Sobrero, A., Boccardo, F., Cittadini, G., Puppo, F., Criscuolo, D., Carmignani, G., Indiveri, F., & Filaci, G. (2013). A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunology, Immunotherapy: CII, 62(6), 1041–1052. https://doi.org/10.1007/s00262-013-1415-9
   PubMed Web of Science ®Google Scholar
• Filaci, G., Fenoglio, D., Nolè, F., Zanardi, E., Tomasello, L., Aglietta, M. I. M., Del Conte, G., Carles, J., Morales-Barrera, R., Guglielmini, P., Scagliotti, G., Signori, A., Parodi, A., Kalli, F., Astone, G., Ferrera, F., Altosole, T., Lamperti, G., Criscuolo, D., Gianese, F., & Boccardo, F. (2021). Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: A randomized phase II trial. Cancer Immunology, Immunotherapy, 70(12), 3679–3692. https://doi.org/10.1007/s00262-021-03024-0
   PubMed Web of Science ®Google Scholar
• Forni, G., Mantovani, A., Forni, G., Mantovani, A., Moretta, L., Rappuoli, R., Rezza, G., Bagnasco, A., Barsacchi, G., Bussolati, G., Cacciari, M., Cappuccinelli, P., Cheli, E., Guarini, R., Bacci, M. L., Mancini, M., Marcuzzo, C., Morrone, M. C., Parisi, G., … Vineis, P. (2021). COVID-19 vaccines: Where we stand and challenges ahead. Cell Death and Differentiation, 28(2), 626–639. https://doi.org/10.1038/s41418-020-00720-9
   PubMed Web of Science ®Google Scholar
• Fourrier, A., Bégaud, B., Alpérovitch, A., Verdier-Taillefer, M. H., Touze, E., Decker, N., & Imbs, J. L. (2001). Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: A comparison between reported and expected number of cases. British Journal of Clinical Pharmacology, 51(5), 489–490. https://doi.org/10.1046/j.1365-2125.2001.01364.x
   PubMed Web of Science ®Google Scholar
• Freeman, B., Lester, S., Mills, L., Rasheed, M. A. U., Moye, S., Abiona, O., Hutchinson, G. B., Morales-Betoulle, M., Krapinunaya, I., Gibbons, A., Chiang, C. F., Cannon, D., Klena, J., Johnson, J. A., Owen, S. M., Graham, B. S., Corbett, K. S., & Thornburg, N. J. (2020). Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. bioRxiv : The Preprint Server for Biology, 1–12. https://doi.org/10.1101/2020.04.24.057323
   Google Scholar
• Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., & Raghava, G. P. S. (2013). In silico approach for predicting toxicity of peptides and proteins. PLoS One. 8(9), e73957. https://doi.org/10.1371/journal.pone.0073957
   PubMed Web of Science ®Google Scholar
• Heide, J., Schulte, S., Kohsar, M., Brehm, T. T., Herrmann, M., Karsten, H., Marget, M., Peine, S., Johansson, A. M., Sette, A., Lütgehetmann, M., Kwok, W. W., Sidney, J., & Zur Wiesch, J. S. (2021). Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19. PLoS Pathogens, 17(9), e1009842. https://doi.org/10.1371/JOURNAL.PPAT.1009842
   PubMed Web of Science ®Google Scholar
• Heitmann, J. S., Bilich, T., Tandler, C., Nelde, A., Maringer, Y., Marconato, M., Reusch, J., Jäger, S., Denk, M., Richter, M., Anton, L., Weber, L. M., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Hörber, S., Peter, A., Meisner, C., … Walz, J. S. (2022). A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature, 601(7894), 617–622. https://doi.org/10.1038/s41586-021-04232-5
   PubMed Web of Science ®Google Scholar
• Jain, S., & Baranwal, M. (2019). Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules. Journal of Theoretical Biology, 465, 34–44. https://doi.org/10.1016/j.jtbi.2019.01.016
   PubMed Web of Science ®Google Scholar
• Jin, X., Ding, Y., Sun, S., Wang, X., Zhou, Z., Liu, X., Li, M., Chen, X., Shen, A., Wu, Y., Liu, B., Zhang, J., Li, J., Yang, Y., Qiu, H., Shen, C., He, Y., & Zhao, G. (2021). Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice. Cellular & Molecular Immunology, 18(12), 2588–2608. https://doi.org/10.1038/s41423-021-00784-8
   PubMed Web of Science ®Google Scholar
• Jung, H. E., & Lee, H. K. (2021). Current understanding of the innate control of toll-like receptors in response to SARS-CoV-2 infection. Viruses, 13(11), 2132. https://doi.org/10.3390/v13112132
   PubMed Web of Science ®Google Scholar
• Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017). NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data. Journal of Immunology (Baltimore, Md.: 1950), 199(9), 3360–3368. https://doi.org/10.4049/jimmunol.1700893
   PubMed Web of Science ®Google Scholar
• Källberg, M., Margaryan, G., Wang, S., Ma, J., & Xu, J. (2014). Raptorx server: A resource for template-based protein structure modeling. Methods in Molecular Biology, 1137, 17–27. https://doi.org/10.1007/978-1-4939-0366-5_2
   Google Scholar
• Kang, S., Yang, M., He, S., Wang, Y., Chen, X., Chen, Y. Q., Hong, Z., Liu, J., Jiang, G., Chen, Q., Zhou, Z., Zhou, Z., Huang, Z., Huang, X., He, H., Zheng, W., Liao, H. X., Xiao, F., Shan, H., & Chen, S. (2021). A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation. Nature Communications, 12(1), 2697. https://doi.org/10.1038/s41467-021-23036-9
   PubMed Web of Science ®Google Scholar
• Kaushal, N., Jain, S., & Baranwal, M. (2022). Computational design of immunogenic peptide constructs comprising multiple human leukocyte antigen restricted dengue virus envelope epitopes. Journal of Molecular Recognitio : JMR, 35(9), e2961. https://doi.org/10.1002/jmr.2961
   PubMed Web of Science ®Google Scholar
• Kayesh, M. E. H., Kohara, M., & Tsukiyama‐kohara, K. (2021). An overview of recent insights into the response of tlr to sars‐cov‐2 infection and the potential of tlr agonists as sars‐cov‐2 vaccine adjuvants. Viruses, 13(11), 2302. https://doi.org/10.3390/v13112302
   PubMed Web of Science ®Google Scholar
• KEGG. (2022). Nucleotide Codes, Amino Acid Codes, and Genetic Codes. https://www.genome.jp/kegg/catalog/codes1.html
   Google Scholar
• Khan, M. T., Islam, M. J., Parihar, A., Islam, R., Jerin, T. J., Dhote, R., Ali, M. A., Laura, F. K., & Halim, M. A. (2021). Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2. Informatics in Medicine Unlocked, 24(April), 100578. https://doi.org/10.1016/j.imu.2021.100578
   PubMedGoogle Scholar
• Ko, J., Park, H., Heo, L., & Seok, C. (2012). GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Research, 40(Web Server issue), W294–297. https://doi.org/10.1093/nar/gks493
   PubMed Web of Science ®Google Scholar
• Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017). The ClusPro web server for protein-protein docking. Nature Protocols, 12(2), 255–278. https://doi.org/10.1038/nprot.2016.169
   PubMed Web of Science ®Google Scholar
• Kumar, R., Christensen, N. D., Kaddis Maldonado, R. J., Bewley, M. C., Ostman, A., Sudol, M., Chen, E. C., Buchkovich, N. W., Gontu, A., Surendran Nair, M., Nissly, R. H., Minns, A. M., Kapur, V., Rossi, R., Kuchipudi, S. V., Lindner, S. E., Parent, L. J., Flanagan, J. M., & Buchkovich, N. J. (2021). Monoclonal antibodies to s and n sars-cov-2 proteins as probes to assess structural and antigenic properties of coronaviruses. Viruses, 13(10), 1899. https://doi.org/10.3390/V13101899/S1
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., Chia, W. N., Chen, M. I. C., Wang, L. F., Ooi, E. E., Kalimuddin, S., Tambyah, P. A., Low, J. G. H., Tan, Y. J., & Bertoletti, A. (2020). SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature, 584(7821), 457–462. https://doi.org/10.1038/s41586-020-2550-z
   PubMed Web of Science ®Google Scholar
• Liu, Y., Liang, Q. Z., Lu, W., Yang, Y.-L., Chen, R., Huang, Y. W., & Wang, B. (2021). A comparative analysis of coronavirus nucleocapsid (N) proteins reveals the SADS-CoV N protein antagonizes IFN-β production by inducing ubiquitination of RIG-I. Frontiers in Immunology, 12, 2269. https://doi.org/10.3389/FIMMU.2021.688758/BIBTEX
   Web of Science ®Google Scholar
• Lu, S., Ye, Q., Singh, D., Cao, Y., Diedrich, J. K., Yates, J. R., Villa, E., Cleveland, D. W., & CoRBett, K. D. (2021). The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nature Communications, 12(1), 502. https://doi.org/10.1038/s41467-020-20768-y
   Web of Science ®Google Scholar
• Marshall, E. (1998). A shadow falls on hepatitis B vaccination effort. Science (New York, N.Y.), 281(5377), 630–631. https://doi.org/10.1126/SCIENCE.281.5377.630
   PubMed Web of Science ®Google Scholar
• Martynova, E., Hamza, S., Markelova, M., Garanina, E., Davidyuk, Y., Shakirova, V., Kaushal, N., Baranwal, M., Stott-Marshall, R. J., Foster, T. L., Rizvanov, A., & Khaiboullina, S. (2022). Immunogenic SARS-CoV-2 S and N protein peptide and cytokine combinations as biomarkers for early prediction of fatal COVID-19. Frontiers in Immunology, 13(March), 830715. https://doi.org/10.3389/fimmu.2022.830715
   PubMedGoogle Scholar
• Matsuo, T. (2021). Viewing SARS-CoV-2 nucleocapsid protein in terms of molecular flexibility. Biology, 10(6), 454. https://doi.org/10.3390/BIOLOGY10060454
   PubMedGoogle Scholar
• McBride, R., van Zyl, M., & Fielding, B. C. (2014). The coronavirus nucleocapsid is a multifunctional protein. Viruses, 6(8), 2991–3018. https://doi.org/10.3390/V6082991
   PubMed Web of Science ®Google Scholar
• Miotto, O., Heiny, A. T., Tan, T. W., Thomas, J. T., & Brusic, V. (2008). Identification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis. BMC Bioinformatics, 9 (Suppl 1), S18. https://doi.org/10.1186/1471-2105-9-S1-S18
   PubMed Web of Science ®Google Scholar
• NIH. (2020). Evaluate the safety, tolerability, immunogenicity and efficacy of UB-311 in mild Alzheimer’s disease (AD) patients. https://clinicaltrials.gov/ct2/show/NCT02551809
   Google Scholar
• Noorimotlagh, Z., Karami, C., Mirzaee, S. A., Kaffashian, M., Mami, S., & Azizi, M. (2020). Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review. International Immunopharmacology, 86, 106738. https://doi.org/10.1016/J.INTIMP.2020.106738
   PubMed Web of Science ®Google Scholar
• Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H., & Lee, J. O. (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 458(7242), 1191–1195. https://doi.org/10.1038/nature07830
   PubMed Web of Science ®Google Scholar
• Peng, Q., Peng, R., Yuan, B., Zhao, J., Wang, M., Wang, X., Wang, Q., Sun, Y., Fan, Z., Qi, J., Gao, G. F., & Shi, Y. (2020). Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2. Cell Reports, 31(11), 107774. https://doi.org/10.1016/j.celrep.2020.107774
   PubMed Web of Science ®Google Scholar
• Pitaloka, D. A. E., Izzati, A., Amirah, S. R., & Syakuran, L. A. (2022). Multi epitope-based vaccine design for protection against Mycobacterium tuberculosis and SARS-CoV-2 coinfection. Advances and Applications in Bioinformatics and Chemistry: AABC, 15(July), 43–57. https://doi.org/10.2147/AABC.S366431
   PubMedGoogle Scholar
• Planas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M. M., Planchais, C., Porrot, F., Robillard, N., Puech, J., Prot, M., Gallais, F., Gantner, P., Velay, A., Le Guen, J., Kassis-Chikhani, N., Edriss, D., Belec, L., Seve, A., … Schwartz, O. (2021). Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature, 596(7871), 276–280. https://doi.org/10.1038/s41586-021-03777-9
   PubMed Web of Science ®Google Scholar
• Popi, A. F., Longo-Maugéri, I. M., & Mariano, M. (2016). An overview of B-1 cells as antigen-presenting cells. Frontiers in Immunology, 7(APR), 138. https://doi.org/10.3389/FIMMU.2016.00138/BIBTEX
   PubMedGoogle Scholar
• Prawiningrum, A. F., Paramita, R. I., & Panigoro, S. S. (2022). Immunoinformatics approach for epitope-based vaccine design: Key steps for breast cancer vaccine. Diagnostics (Basel, Switzerland), 12(12), 2981. https://doi.org/10.3390/diagnostics12122981
   PubMedGoogle Scholar
• Ram Benny Dessau, C. B. P. (2008). R"–project for statistical computing. Ugeskrift for Laeger, 170(5), 328–330.
   PubMedGoogle Scholar
• Rehman, Z., Fahim, A., & Bhatti, M. F. (2021). Scouting the receptor-binding domain of SARS coronavirus 2: A comprehensive immunoinformatics inquisition. Future Virology, 16(2), 117–132. https://doi.org/10.2217/fvl-2020-0269
   Web of Science ®Google Scholar
• Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., Peters, B., Nielsen, M., & Nielsen, M. (2020). Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. Journal of Proteome Research, 19(6), 2304–2315. https://doi.org/10.1021/acs.jproteome.9b00874
   PubMed Web of Science ®Google Scholar
• Rodríguez, Y., M., Rojas, S., Beltran, F., Polo, L., Camacho-Domínguez, S. D., Morales, M., Eric, Gershwin., & J.-M., Anaya. (2022). Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. Journal of Autoimmunity, 132, 102898. https://doi.org/10.1016/j.jaut.2022.102898
   PubMed Web of Science ®Google Scholar
• Snyder, T. M., Gittelman, R. M., Klinger, M., May, D. H., Osborne, E. J., Taniguchi, R., Zahid, H. J., Kaplan, I. M., Dines, J. N., Noakes, M. T., Pandya, R., Chen, X., Elasady, S., Svejnoha, E., Ebert, P., Pesesky, M. W., De ALMeida, P., O’Donnell, H., DeGottardi, Q., … Field, R. H. (2020). Magnitude and dynamics of the T-Cell response to SARS-CoV-2 infection at both individual and population levels.  The Preprint Server for Health Sciences.
   Google Scholar
• Srinivasan, S., Selvaraj, G., Gopalan, V., Padmanabhan, P., Ramesh, K., Govindan, K., Chandran, A., Dhandapani, P., Krishnasamy, K., & Kitambi, S. (2022). Epitope identification and designing a potent multi-epitope vaccine construct against SARS-CoV-2 including the emerging variants. Journal of Global Infectious Diseases, 14(1), 24–30. https://doi.org/10.4103/jgid.jgid_96_21
   PubMed Web of Science ®Google Scholar
• Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021). The biological and clinical significance of emerging SARS-CoV-2 variants. Nature Reviews. Genetics, 22(12), 757–773. https://doi.org/10.1038/s41576-021-00408-x
   PubMed Web of Science ®Google Scholar
• Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., Methot, N., Phillips, E., Mallal, S., Frazier, A., Rawlings, S. A., Greenbaum, J. A., Peters, B., Smith, D. M., Crotty, S., … Sette, A. (2021). Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports. Medicine, 2(2), 100204. https://doi.org/10.1016/j.xcrm.2021.100204
   PubMedGoogle Scholar
• Team, V. G. C. V. T. (2023). Vaccines candidates in clinical trials. https://covid19.trackvaccines.org/vaccines/#approved
   Google Scholar
• Thakur, S., Sasi, S., Pillai, S. G., Nag, A., Shukla, D., Singhal, R., Phalke, S., & Velu, G. S. K. (2022). SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines. Frontiers in Medicine, 9(February), 815389. https://doi.org/10.3389/fmed.2022.815389
   Google Scholar
• Tilocca, B., Soggiu, A., Sanguinetti, M., Musella, V., Britti, D., Bonizzi, L., Urbani, A., & Roncada, P. (2020). Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses. Microbes and Infection, 22(4-5), 188–194. https://doi.org/10.1016/j.micinf.2020.04.002
   PubMed Web of Science ®Google Scholar
• Trollfors, B. (2020). Itching nodules and aluminium allergy following vaccination with aluminium-adsorbed vaccines—Not a negligible problem. Acta Paediatrica (Oslo, Norway: 1992), 109(12), 2444–2445. https://doi.org/10.1111/apa.15487
   PubMed Web of Science ®Google Scholar
• Vadalà, M., Poddighe, D., Laurino, C., & Palmieri, B. (2017). Vaccination and autoimmune diseases: Is prevention of adverse health effects on the horizon? The EPMA Journal, 8(3), 295–311. https://doi.org/10.1007/s13167-017-0101-y
   PubMed Web of Science ®Google Scholar
• Verhagen, J., van der Meijden, E. D., Lang, V., Kremer, A. E., Völkl, S., Mackensen, A., Aigner, M., & Kremer, A. N. (2021). Human CD4+ T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential. Clinical and Experimental Immunology, 205(3), 363–378. https://doi.org/10.1111/cei.13627
   PubMed Web of Science ®Google Scholar
• Wang, Q., McLoughlin, R. M., Cobb, B. A., Charrel-Dennis, M., Zaleski, K. J., Golenbock, D., TzIAnabos, A. O., & Kasper, D. L. (2006). A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. The Journal of Experimental Medicine, 203(13), 2853–2863. https://doi.org/10.1084/JEM.20062008
   PubMed Web of Science ®Google Scholar
• Waqas, M., Haider, A., Rehman, A., Qasim, M., Umar, A., Sufyan, M., Akram, H. N., Mir, A., RaZZaq, R., Rasool, D., Tahir, R. A., & Sehgal, S. A. (2021). Immunoinformatics and molecular docking studies predicted potential multiepitope-based peptide vaccine and novel compounds against novel SARS-CoV-2 through virtual screening. BioMed Research International, 2021, 1596834–1596820. https://doi.org/10.1155/2021/1596834
   PubMed Web of Science ®Google Scholar
• Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009). Jalview Version 2-A multiple sequence alignment editor and analysis workbench. Bioinformatics (Oxford, England), 25(9), 1189–1191. https://doi.org/10.1093/bioinformatics/btp033
   PubMed Web of Science ®Google Scholar
• WHO. (2023). WHO Coronavirus (COVID-19) Dashboard. World Health Organization. https://covid19.who.int/
   Google Scholar
• Wieczorek, M., Abualrous, E. T., Sticht, J., Álvaro-Benito, M., Stolzenberg, S., Noé, F., & Freund, C. (2017). Major histocompatibility complex (MHC) class I and MHC class II proteins: Conformational plasticity in antigen presentation. Frontiers in Immunology, 8(MAR), 292. https://doi.org/10.3389/fimmu.2017.00292
   PubMedGoogle Scholar
• World health organization (WHO). (2022a). COVID-19 advice for the public: Getting vaccinated. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice
   Google Scholar
• World health organization (WHO). (2022b). Statement on Omicron sublineage BA.2. WHO. https://www.who.int/news/item/22-02-2022-statement-on-omicron-sublineage-ba.2
   Google Scholar
• Yadav, P. D., Sahay, R. R., Sapkal, G., Nyayanit, D., Shete, A. M., Deshpande, G., Patil, D. Y., Gupta, N., Kumar, S., Abraham, P., Panda, S., & Bhargava, B. (2021). Comparable neutralization of SARS-CoV-2 Delta AY.1 AND Delta with individuals sera vaccinated with BBV152. Journal of Travel Medicine, 28(8), 1–4. https://doi.org/10.1093/jtm/taab154
   Web of Science ®Google Scholar
• Ye, Q., Lu, S., & Corbett, K. D. (2021). Structural basis for SARS-CoV-2 nucleocapsid protein recognition by single-domain antibodies. Frontiers in Immunology, 12(858), 719037. https://doi.org/10.3389/fimmu.2021.719037
   PubMedGoogle Scholar
• Zaheer, T., Waseem, M., Waqar, W., Dar, H. A., Shehroz, M., Naz, K., Ishaq, Z., Ahmad, T., Ullah, N., Bakhtiar, S. M., Muhammad, S. A., & Ali, A. (2020). Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences. PeerJ. 8, e9541. https://doi.org/10.7717/peerj.9541
   PubMed Web of Science ®Google Scholar
• Zhao, J., Wang, L., Schank, M., Dang, X., Lu, Z., Cao, D., Khanal, S. u. shant., Nguyen, L. N., Nguyen, L. N. T., Zhang, J., Zhang, Y., Adkins, J. L., Baird, E. M., Wu, X. Y., Ning, S., Gazzar, M. E., Moorman, J. P., & Yao, Z. Q. (2021). Z. Q. (2021). SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Virus Research, 304, 198508. https://doi.org/10.1016/J.VIRUSRES.2021.198508
   PubMed Web of Science ®Google Scholar
• Zhou, P., Jin, B., Li, H., & Huang, S. Y. (2018). HPEPDOCK: A web server for blind peptide-protein docking based on a hierarchical algorithm. Nucleic Acids Research, 46(W1), W443–W450. https://doi.org/10.1093/nar/gky357
   PubMed Web of Science ®Google Scholar